TABLE-Cmic <2309.T>-2008/09 group results

Nov 6 (Reuters) -

CMIC CO LTD

CONSOLIDATED FINANCIAL HIGHLIGHTS

(in billions of yen unless specified)

Year ended Year ended Year to Six months to

Sep 30, 2009 Sep 30, 2008 Sep 30, 2010 Mar 31, 2010

LATEST YEAR-AGO COMPANY COMPANY

RESULTS RESULTS FORECASTS H1 FORECASTS
Sales 28.78 25.78 34.00 15.00

(+11.7 pct) (+19.2 pct) (+18.1%) (+5.5%)
Operating 2.51 2.28 3.00 1.35

(+10.5 pct) (+5.3 pct) (+19.3%) (+0.3%)
Recurring 2.40 2.19 2.60 1.10

(+9.7 pct) (+1.6 pct) (+8.3%) (-14.7%)
Net 1.06 829 mln 1.20 500 mln

(+27.7 pct) (-30.7 pct) (+13.2%) (-19.2%)
EPS Y1,205.63 Y1,003.94 Y1,365.27 Y568.86
Annual div Y334.00 Y266.00 Y380.00
-Q2 div Y167.00 Y133.00 Y190.00
-Q4 div Y167.00 Y133.00 Y190.00

NOTE - Cmic Co Ltd conducts clinical trials on behalf of
pharmaceutical makers.

For latest earnings estimates made by Toyo Keizai, please
double click on 2309.TK1.